All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F18%3A73590410" target="_blank" >RIV/61989592:15110/18:73590410 - isvavai.cz</a>

  • Alternative codes found

    RIV/68378050:_____/18:00502682 RIV/00023736:_____/18:00012484

  • Result on the web

    <a href="http://www.bloodjournal.org/content/bloodjournal/132/25/2695.full.pdf" target="_blank" >http://www.bloodjournal.org/content/bloodjournal/132/25/2695.full.pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1182/blood-2018-04-843060" target="_blank" >10.1182/blood-2018-04-843060</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms

  • Original language description

    Clinical consequences of driver mutations in myeloproliferative neoplasms (MPNs) are well established, yet little is known about the impact of co-occurring JAK2 variants on the phenotype of MPNs. We tested a cohort of 390 JAK2 V617F-positive MPN patients for JAK2 R1063H, a variant previously described in polycythemia vera and hereditary erythrocytosis. We identified 14 carriers of both JAK2 V617F and JAK2 R1063H mutations. These patients exhibited significantly higher rate of neutrophilic granulocytosis compared to those harboring JAK2 V617F only. Quantification of R1063H allele in the genomic DNA samples indicated that the variant was inherited in 8 cases, with an allele burden around 50%. In 3 other patients with high JAK2 V617F allelic burden, the JAK2 R1063H was nearly homozygous (&gt;80%), suggesting the acquisition of the second allele by uniparental disomy. In 3 patients the R1063H mutation was acquired (allele percentage between 20.7% - 31.5%). Our functional studies demonstrated that the JAK2 V617F-induced signaling via the dimeric myeloid cytokine receptors is increased in the presence of the R1063H when the two mutations are in cis. Thus, acquisition of V617F in cis on a germline R1063H allele, or an acquisition of additional R1063H mutation increases JAK2 V617F oncogenic signaling that promotes neutrophilia.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30205 - Hematology

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    BLOOD

  • ISSN

    0006-4971

  • e-ISSN

  • Volume of the periodical

    132

  • Issue of the periodical within the volume

    25

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    5

  • Pages from-to

    2695-2699

  • UT code for WoS article

    000453926500012

  • EID of the result in the Scopus database

    2-s2.0-85058788204